FDA Clears Optomed’s Handheld AI Screening Device for Diabetic Retinopathy in the US
The Aurora AEYE is the first FDA-approved handheld AI fundus camera. Optomed (Helsinki, Finland) has announced that its handheld fundus…
Perfuse Therapeutics Shares Promising Phase IIa Results in Glaucoma and Diabetic Retinopathy
Could better blood flow be the key to treating glaucoma and diabetic retinopathy? New findings suggest it just might. Sometimes…
popular posts
latest posts
